miR-223-5p
rnamiR-223-5p modulates myeloid cell activation and inflammatory responses associated with coronary artery disease.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleRegulates leukocyte and platelet function; plaque inflammation biomarker.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- Platelet MicroRNA-484 as a Novel Diagnostic Biomarker for Acute Coronary Syndrome.Laboratory medicine · 2023 · PMID 36214592 · doi